University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > SFGH PHP Grand Rounds > MDR-XDR Tuberculosis > Daley > Slides
Treatment and Prevention of MDR and XDR-TB
Slide 1.

Charles L. Daley
Slide 1.

Treatment and Prevention of MDR and XDR-TB
Slide 2.

In Vitro Drug Susceptibility Methods
Slide 3.

Agar Proportion Method
Slide 4.

Mutations Associated with Drug Resistance
Slide 5.

Microscopic Observation Drug-Susceptibility Assay (MODS)
Slide 6.

Microscopic Observation Drug-Susceptibility Assay (MODS)
Slide 7.

Antituberculosis Drugs in Use
Slide 8.

Building a Treatment Regimen for MDR-TB
Slide 9.

Treatment Regimens for MDR-TB
Slide 10.

Treatment Outcomes of MDR-TB
Slide 11.

TB Treatment Outcomes, by Selected Drug Resistance Patterns, Latvia, 2000-2003*
Slide 12.

MDR Tuberculosis Predictors of Success and Failure
Slide 13.

Role of Surgery in Treatment of MDR-TB
Slide 14.

Role of Surgery in Treatment of MDR-TB at NJC
Slide 15.

Surgery for DR-TB in Peru
Slide 16.

Outcome of Treatment for MDR-TB by HIV Status
Slide 17.

Treatment of HIV-related MDR-TB
Slide 18.

Evolution of Drug Resistance
Slide 19.

WHO Stop TB Strategy
Slide 20.

Structure of the Stop TB Partnership
Slide 21.

The Current Drug Pipeline for Anti-TB Medications
Slide 1.

Thank You!
Slide 1.